🇺🇸 FDA
Pipeline program

Inhaled treprostinil solution

RIN-PH-305

Phase 3 small_molecule terminated

Quick answer

Inhaled treprostinil solution for Pulmonary Hypertension is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 2 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Pulmonary Hypertension
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials